My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.

    Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA.

    Diabetes Care. 2009 Feb;32(2):240-4. Epub 2008 Nov 18.PMID: 19017777 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.

    Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM; Insulin Aspart Pediatric Pump Study Group.

    Diabetes Care. 2008 Feb;31(2):210-5. Epub 2007 Nov 5.PMID: 17989308 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

    Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

    Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

    Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

    Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study.

    Heise T, Eckers U, Kanc K, Nielsen JN, Nosek L.

    Diabetes Technol Ther. 2008 Dec;10(6):479-85.PMID: 19049377 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.

    Hirao K, Maeda H, Urata S, Takisawa Y, Hirao S, Sasako T, Sasaki T.

    Clin Ther. 2007 May;29(5):927-34.PMID: 17697911 [PubMed - indexed for MEDLINE]Related articles

    7.

    Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

    Renner R, Pfützner A, Trautmann M, Harzer O, Sauter K, Landgraf R.

    Diabetes Care. 1999 May;22(5):784-8.PMID: 10332682 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

    Attia N, Jones TW, Holcombe J, Tamborlane WV.

    Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.

    Bartolo PD, Pellicano F, Scaramuzza A, Sardu C, Casetti T, Bosi E, Miselli V, Brandolini S, Fabbri T, Meandri P, Cannatà F.

    Diabetes Technol Ther. 2008 Dec;10(6):495-8.PMID: 19049379 [PubMed - indexed for MEDLINE]Related articles

    12.

    A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

    Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR.

    Diabetes Care. 2005 May;28(5):1107-12.PMID: 15855574 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.

    Cernea S, Kidron M, Wohlgelernter J, Raz I.

    Clin Ther. 2005 Oct;27(10):1562-70.PMID: 16330292 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

    Melki V, Renard E, Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P, Jeandidier N, Meyer L, Blin P, Augendre-Ferrante B, Tauber JP.

    Diabetes Care. 1998 Jun;21(6):977-82.PMID: 9614617 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.

    Bode BW, Strange P.

    Diabetes Care. 2001 Jan;24(1):69-72.PMID: 11194244 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

    Clin Ther. 2009 May;31(5):980-7.PMID: 19539098 [PubMed - indexed for MEDLINE]Related articles

    17.

    A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

    Diabetes Care. 2004 Jul;27(7):1554-8.PMID: 15220227 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.

    Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groele L.

    Pediatr Diabetes. 2009 Aug;10(5):298-303. Epub 2008 Oct 20.PMID: 19175902 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.

    Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP.

    Diabetes Technol Ther. 2004 Feb;6(1):9-15.PMID: 15000764 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

    Bode BW.

    Clin Ther. 2007;29 Suppl D:S135-44.PMID: 18191065 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity